Nektar Therapeutics
Closed
70.54 -1.3
Overview
Share price change
24h
Min
69.36
Max
70.97
Income | -8.8M -45M |
|---|---|
Sales | -11M 11M |
EPS | -1.78 |
Profit margin | -413.443 |
Employees | 63 |
EBITDA | -18M -37M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +118.11% upside |
Next Earnings | 13 sie 2026 |
|---|
Market Cap | -521M 2.4B |
|---|---|
Previous open | 71.84 |
Previous close | 70.54 |
Nektar Therapeutics Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Nektar Therapeutics Forecast
Price Target
By TipRanks
118.11% upside
12 Months Forecast
Average 154.14 USD 118.11%
High 192 USD
Low 80 USD
Based on 9 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$